Skip to main content
APTAMER GROUP PLC logo

APTAMER GROUP PLC — Investor Relations & Filings

Ticker · APTA ISIN · GB00BNRRP542 LEI · 213800Y4XGH3WJNBE686 IL Professional, scientific and technical activities
Open in API
Filings indexed 202 across all filing types
Latest filing 2023-06-14 Regulatory Filings
Country GB United Kingdom
Listing IL APTA

About APTAMER GROUP PLC

https://aptamergroup.com/

Aptamer Group PLC is a life sciences company that develops custom affinity binders to address targeting challenges in research, diagnostics, and therapeutics. The company's core technology is the Optimer® platform, which discovers and develops proprietary, next-generation aptamer-based binders. These Optimer binders are engineered for high specificity, stability, and manufacturability. The company provides custom development services, partnering with global pharmaceutical, diagnostic, and biotechnology organizations to support their programs from early discovery through to clinical development. Key application areas include the development of novel therapeutics, advanced diagnostic assays, bioprocessing workflows, and biomarker discovery.

Recent filings

Filing Released Lang Actions
Aptamer & Neuro-Bio to develop Alzheimer’s test
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated June 14, 2023. It announces a partnership between Aptamer Group and Neuro-Bio regarding an Alzheimer's disease diagnostic test. The text concludes with contact information for various advisors and a disclaimer stating, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This structure is characteristic of a general regulatory news service announcement, which is often used for material non-public information that doesn't fit a more specific SEC filing category (like 10-K or ER). Since it is a general announcement distributed via RNS and does not detail specific financial results (ER/IR), management changes (MANG), or proxy materials (DEF 14A/PSI), the most appropriate classification is the general regulatory announcement category, RNS.
2023-06-14 English
Aptamer Group: Directorate Change
Board/Management Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 8639Y) on May 10, 2023. The primary subject is 'Directorate Changes,' specifically announcing the immediate departure of the CEO and Board Director, Dr. Arron Tolley, and the appointment of interim replacements. This content directly matches the definition for Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. Although it is distributed via RNS, the specific content dictates the MANG classification over the general RNS fallback.
2023-05-10 English
Trading Update
Regulatory Filings Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' It contains a 'Trading Update' for the year ending 30 June 2023, providing unaudited revenue figures for the ten months ended 30 April 2023, cash balance, and commentary on expected performance and funding needs. This is a periodic operational and financial update, but it is not a full Annual Report (10-K) or a comprehensive Interim Report (IR). Since it is a formal announcement distributed via the RNS system, and it doesn't fit perfectly into the specific categories like ER (Earnings Release, which is usually just highlights) or IR (Interim Report, which is comprehensive), the most appropriate classification is the general regulatory announcement category, RNS, as it is the primary distribution channel and nature of the filing. However, upon closer inspection, the content is a 'Trading Update' which provides key financial metrics (revenue, cash balance) and outlook, which strongly aligns with an Earnings Release (ER) or a preliminary update preceding a full report. Given the context of providing key financial figures for a period (ten months) and discussing future expectations, ER is a strong candidate. But because the document is explicitly branded as an RNS release and is a general update rather than a structured earnings release format, RNS serves as the most accurate catch-all for this type of regulatory news service filing.
2023-05-05 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (3778 characters) and begins with 'National Storage Mechanism' and 'RNS Number : 4940V'. The content explicitly states the company's total voting rights (69,091,717 Ordinary Shares) as of the announcement date, referencing compliance with the FCA's Disclosure Guidance and Transparency Rules. This type of mandatory, short-form regulatory update, often disseminated via the RNS system, does not fit the definitions for a comprehensive report (10-K, IR), a management change (MANG), or a dividend notice (DIV). It is a general regulatory announcement disseminated through the RNS system, but specifically concerns voting rights/share structure, which is often covered under general regulatory disclosures. Given the context of RNS dissemination and the nature of the announcement (Total Voting Rights), it fits best under the general regulatory filing category (RNS) or potentially a specific voting rights announcement if one existed, but DVA is for voting *results*. Since it is a standard, short regulatory disclosure via RNS, RNS is the most appropriate general classification, although it is closely related to share structure changes. However, since the core purpose is a mandatory disclosure under FCA rules regarding the total number of shares/voting rights, which is a fundamental regulatory filing, RNS is the correct fallback for this type of RNS announcement.
2023-04-05 English
Optimer-Fc launched for immunohistochemistry
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement from the London Stock Exchange's news service (RNS). The content describes a new product launch ('Optimer®-Fc') and ongoing commercial discussions with pharmaceutical companies. This is a general business update or news release, not a formal financial report (like 10-K or IR), a specific voting result (DVA), or a management change (MANG). Since it is a general regulatory announcement that doesn't fit the highly specific categories like ER, DIV, or CAP, the most appropriate classification is the general regulatory filing category, RNS.
2023-03-20 English
Investor Webinar
Regulatory Filings Classification · 95% confidence The document is identified by the RNS Number (2887T) and the date format typical of regulatory news services. The content announces an 'Investor Webinar' where management will share an update, but explicitly states, 'No new information will be disclosed during the event.' This structure—announcing a future event where no material, non-public information will be shared—is a common type of corporate communication. Since it is a formal announcement distributed via RNS and does not fit the specific definitions for earnings releases (ER), capital changes (CAP), or director dealings (DIRS), it falls best under the general regulatory announcement category. Given the nature of announcing a non-material investor presentation, it is classified as a general Regulatory Filing (RNS), as it is a formal notification to the market via the RNS system, even if it is a 'Reach' (non-regulatory news service) distribution.
2023-03-17 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.